Memantine attenuates responses of spinothalamic tract cells to cutaneous stimulation in neuropathic monkeys

scientific article published on 01 January 1998

Memantine attenuates responses of spinothalamic tract cells to cutaneous stimulation in neuropathic monkeys is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S1090-3801(98)90019-2
P698PubMed publication ID15102383

P2093author name stringW D Willis
H Rees
S M Carlton
M Tsuruoka
P2860cites workTreatment with the NMDA antagonist memantine attenuates nociceptive responses to mechanical stimulation in neuropathic ratsQ70980476
An instrument using a multiple layer Peltier device to change skin temperature rapidlyQ71321345
The clinically tested N-methyl-D-aspartate receptor antagonist memantine blocks and reverses thermal hyperalgesia in a rat model of painful mononeuropathyQ71899573
Behavioral manifestations of an experimental model for peripheral neuropathy produced by spinal nerve ligation in the primateQ72007006
The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humansQ28243687
Evidence of a role for NMDA receptors in pain perceptionQ28253098
Ethical guidelines for investigations of experimental pain in conscious animalsQ29617510
High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgiaQ34426464
Evidence for presynaptic N-methyl-D-aspartate autoreceptors in the spinal cord dorsal hornQ35702669
Light and electron microscope distribution of the NMDA receptor subunit NMDAR1 in the rat nervous system using a selective anti-peptide antibodyQ36762062
A cure for wind up: NMDA receptor antagonists as potential analgesicsQ37890801
Systemic ketamine attenuates nociceptive behaviors in a rat model of peripheral neuropathyQ39466007
Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgiaQ39475248
Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial painQ39475255
Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placeboQ39482050
Causalgia. A centennial reviewQ40044925
The effects of a non-competitive NMDA receptor antagonist, MK-801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammationQ41102806
Comparison of ketamine and pethidine in experimental and postoperative painQ41350025
Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathyQ43547058
Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathyQ44896162
Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy.Q45092798
Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat.Q45267214
The role of NMDA and non-NMDA excitatory amino acid receptors in the excitation of primate spinothalamic tract neurons by mechanical, chemical, thermal, and electrical stimuliQ45272317
Classification of primate spinothalamic and somatosensory thalamic neurons based on cluster analysisQ48313154
Region-specific expression of subunits of ionotropic glutamate receptors (AMPA-type, KA-type and NMDA receptors) in the rat spinal cord with special reference to nociceptionQ48316479
The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injuryQ48442492
MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathyQ48690138
Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-D-aspartateQ48708407
Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects.Q51590011
Beneficial effects of ketamine in a chronic pain state with allodynia, possibly due to central sensitization.Q51611375
The involvement of N-methyl-D-aspartate (NMDA) and non-NMDA receptors in the responsiveness of rat spinal neurons with input from the chronically inflamed ankle.Q51636145
Memantine selectively depresses NMDA receptor-mediated responses of ratspinal neurones in vivo.Q51642827
Response of chronic neuropathic pain syndromes to ketamine: a preliminary study.Q51644389
Spinal cord amino acid release and content in an arthritis model: the effects of pretreatment with non-NMDA, NMDA, and NK1 receptor antagonists.Q51650419
Ketamine hydrochloride in the treatment of phantom limb pain.Q51659607
Responses of spinothalamic tract neurons to mechanical and thermal stimuli in an experimental model of peripheral neuropathy in primatesQ51678980
Treatment of Impaired Cerebral Function in Psychogeriatric Patients with Memantine - Results of a Phase II Double-Blind StudyQ52123964
The induction and maintenance of central sensitization is dependent on N -methyl-d-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity statesQ52237708
Dextrorphan relieves neuropathic heat-evoked hyperalgesia in the rat.Q53756167
Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease.Q54070438
Excitatory amino acid receptors and nociceptive neurotransmission in rat spinal cordQ68094181
Changes in the response states of primate spinothalamic tract cells caused by mechanical damage of the skin or activation of descending controlsQ68205269
P433issue3
P304page(s)229-238
P577publication date1998-01-01
P1433published inEuropean Journal of PainQ4548992
P1476titleMemantine attenuates responses of spinothalamic tract cells to cutaneous stimulation in neuropathic monkeys
P478volume2